• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

过氧化物酶体增殖物激活受体γ激动剂通过抑制诱导型一氧化氮合酶,保护小脑颗粒细胞免受细胞因子诱导的凋亡性细胞死亡。

Peroxisome proliferator-activated receptor gamma agonists protect cerebellar granule cells from cytokine-induced apoptotic cell death by inhibition of inducible nitric oxide synthase.

作者信息

Heneka M T, Feinstein D L, Galea E, Gleichmann M, Wüllner U, Klockgether T

机构信息

Department of Neurology, University of Bonn, Germany.

出版信息

J Neuroimmunol. 1999 Dec;100(1-2):156-68. doi: 10.1016/s0165-5728(99)00192-7.

DOI:10.1016/s0165-5728(99)00192-7
PMID:10695726
Abstract

Cerebellar granule cells (CGCs) can express the inducible isoform of nitric oxide synthase (iNOS) in response to inflammatory stimuli. We demonstrate that induction of iNOS in CGCs by bacterial lipopolysaccharide and pro-inflammatory cytokines results in cell death that was potentiated by excess L-arginine and inhibited by the selective iNOS inhibitor, 2-amino-5,6-dihydro-6-methyl-4H-1,3-thiazine. The NO-mediated cell death was accompanied by increased caspase-3-like activity, DNA fragmentation and positive terminal transferase dUTP nick end labeling (TUNEL), suggesting that apoptosis mediates CGC cell death. Incubation of CGCs with the non-steroidal anti-inflammatory drugs (NSAIDs), ibuprofen or indomethacin, or with 15-deoxy-delta12,14 prostaglandin J2 (PGJ2) downregulates iNOS expression and reduces subsequent cell death. Since in other cell types, both NSAIDs and PGJ2 can activate the peroxisome proliferator-activated receptor-gamma (PPARgamma) and downregulate cytokine levels and iNOS expression, and since CGCs express PPARgamma in vivo and in vitro, our data suggest that activation of CGC PPARgamma mediates iNOS suppression and reduced cell death. Because PPARgamma is expressed in brains of Alzheimer's Disease (AD) patients, in which neuronal iNOS expression and apoptotic cell death have been described, these results may help explain the basis for the beneficial effects of NSAIDs in AD.

摘要

小脑颗粒细胞(CGCs)可在炎症刺激下表达诱导型一氧化氮合酶(iNOS)。我们证明,细菌脂多糖和促炎细胞因子诱导CGCs中的iNOS会导致细胞死亡,过量的L-精氨酸会增强这种细胞死亡,而选择性iNOS抑制剂2-氨基-5,6-二氢-6-甲基-4H-1,3-噻嗪可抑制这种细胞死亡。NO介导的细胞死亡伴随着caspase-3样活性增加、DNA片段化以及阳性末端转移酶dUTP缺口末端标记(TUNEL),这表明凋亡介导了CGC细胞死亡。用非甾体抗炎药(NSAIDs)布洛芬或吲哚美辛,或用15-脱氧-Δ12,14前列腺素J2(PGJ2)孵育CGCs可下调iNOS表达并减少随后的细胞死亡。由于在其他细胞类型中,NSAIDs和PGJ2均可激活过氧化物酶体增殖物激活受体γ(PPARγ)并下调细胞因子水平和iNOS表达,且CGCs在体内和体外均表达PPARγ,我们的数据表明,CGC的PPARγ激活介导了iNOS抑制和细胞死亡减少。因为PPARγ在阿尔茨海默病(AD)患者的大脑中表达,而在AD患者大脑中已描述了神经元iNOS表达和凋亡性细胞死亡,这些结果可能有助于解释NSAIDs在AD中产生有益作用的基础。

相似文献

1
Peroxisome proliferator-activated receptor gamma agonists protect cerebellar granule cells from cytokine-induced apoptotic cell death by inhibition of inducible nitric oxide synthase.过氧化物酶体增殖物激活受体γ激动剂通过抑制诱导型一氧化氮合酶,保护小脑颗粒细胞免受细胞因子诱导的凋亡性细胞死亡。
J Neuroimmunol. 1999 Dec;100(1-2):156-68. doi: 10.1016/s0165-5728(99)00192-7.
2
Peroxisome proliferator-activated receptor-gamma ligands reduce neuronal inducible nitric oxide synthase expression and cell death in vivo.过氧化物酶体增殖物激活受体γ配体可降低体内神经元诱导型一氧化氮合酶的表达并减少细胞死亡。
J Neurosci. 2000 Sep 15;20(18):6862-7. doi: 10.1523/JNEUROSCI.20-18-06862.2000.
3
Peroxisome proliferator--activated receptor gamma activators inhibit interleukin-1beta-induced nitric oxide and matrix metalloproteinase 13 production in human chondrocytes.过氧化物酶体增殖物激活受体γ激活剂可抑制白细胞介素-1β诱导的人软骨细胞中一氧化氮和基质金属蛋白酶13的产生。
Arthritis Rheum. 2001 Mar;44(3):595-607. doi: 10.1002/1529-0131(200103)44:3<595::AID-ANR108>3.0.CO;2-8.
4
Activators of peroxisome proliferator-activated receptor-gamma (PPARgamma) inhibit inducible nitric oxide synthase expression but increase heme oxygenase-1 expression in rat glial cells.过氧化物酶体增殖物激活受体γ(PPARγ)激动剂可抑制大鼠神经胶质细胞中诱导型一氧化氮合酶的表达,但可增加血红素加氧酶-1的表达。
Neurosci Lett. 1999 Mar 5;262(2):129-32. doi: 10.1016/s0304-3940(99)00055-5.
5
Anti-inflammatory actions of 15-deoxy-delta 12,14-prostaglandin J2 and troglitazone: evidence for heat shock-dependent and -independent inhibition of cytokine-induced inducible nitric oxide synthase expression.15-脱氧-Δ12,14-前列腺素J2和曲格列酮的抗炎作用:细胞因子诱导的诱导型一氧化氮合酶表达的热休克依赖性和非依赖性抑制的证据
Diabetes. 2000 Mar;49(3):346-55. doi: 10.2337/diabetes.49.3.346.
6
Inhibition of IFN-gamma-mediated inducible nitric oxide synthase induction by the peroxisome proliferator-activated receptor gamma agonist, 15-deoxy-delta 12,14-prostaglandin J2, involves inhibition of the upstream Janus kinase/STAT1 signaling pathway.过氧化物酶体增殖物激活受体γ激动剂15-脱氧-Δ12,14-前列腺素J2对IFN-γ介导的诱导型一氧化氮合酶诱导的抑制作用涉及对上游Janus激酶/STAT1信号通路的抑制。
J Immunol. 2003 Jul 15;171(2):979-88. doi: 10.4049/jimmunol.171.2.979.
7
The 15-deoxy-delta12,14-prostaglandin J2 inhibits the inflammatory response in primary rat astrocytes via down-regulating multiple steps in phosphatidylinositol 3-kinase-Akt-NF-kappaB-p300 pathway independent of peroxisome proliferator-activated receptor gamma.15-脱氧-Δ12,14-前列腺素J2通过下调磷脂酰肌醇3-激酶-Akt-NF-κB-p300途径中的多个步骤来抑制原代大鼠星形胶质细胞中的炎症反应,该过程独立于过氧化物酶体增殖物激活受体γ。
J Immunol. 2004 Oct 15;173(8):5196-208. doi: 10.4049/jimmunol.173.8.5196.
8
Cyclopentenone prostaglandins suppress activation of microglia: down-regulation of inducible nitric-oxide synthase by 15-deoxy-Delta12,14-prostaglandin J2.环戊烯酮前列腺素可抑制小胶质细胞的激活:15-脱氧-Δ12,14-前列腺素J2对诱导型一氧化氮合酶的下调作用。
Proc Natl Acad Sci U S A. 1999 Apr 13;96(8):4668-73. doi: 10.1073/pnas.96.8.4668.
9
Inhibition of inducible nitric oxide synthase by peroxisome proliferator-activated receptor agonists: correlation with induction of heme oxygenase 1.过氧化物酶体增殖物激活受体激动剂对诱导型一氧化氮合酶的抑制作用:与血红素加氧酶1诱导的相关性
J Immunol. 1998 Jul 15;161(2):978-84.
10
Effects of peroxisome proliferator-activated receptor agonists on LPS-induced neuronal death in mixed cortical neurons: associated with iNOS and COX-2.过氧化物酶体增殖物激活受体激动剂对脂多糖诱导的混合皮质神经元死亡的影响:与诱导型一氧化氮合酶和环氧化酶-2相关
Brain Res. 2002 Jun 21;941(1-2):1-10. doi: 10.1016/s0006-8993(02)02480-0.

引用本文的文献

1
Ethnopharmacological Profile, Phytochemistry and Therapeutic Potential of L. for the Treatment of Neurological Disorders.L. 用于治疗神经系统疾病的民族药理学概况、植物化学及治疗潜力
J Nutr Metab. 2025 Jun 11;2025:2275526. doi: 10.1155/jnme/2275526. eCollection 2025.
2
Supplementation of Regular Diet With Medium-Chain Triglycerides for Procognitive Effects: A Narrative Review.在常规饮食中补充中链甘油三酯以产生促认知作用:一项叙述性综述。
Front Nutr. 2022 Jul 15;9:934497. doi: 10.3389/fnut.2022.934497. eCollection 2022.
3
Transcriptomic Analysis of HCN-2 Cells Suggests Connection among Oxidative Stress, Senescence, and Neuron Death after SARS-CoV-2 Infection.
转录组分析 HCN-2 细胞提示 SARS-CoV-2 感染后氧化应激、衰老和神经元死亡之间的联系。
Cells. 2021 Aug 25;10(9):2189. doi: 10.3390/cells10092189.
4
PPARγ and Cognitive Performance.过氧化物酶体增殖物激活受体γ 与认知表现。
Int J Mol Sci. 2019 Oct 12;20(20):5068. doi: 10.3390/ijms20205068.
5
Ibuprofen Treatment Reduces the Neuroinflammatory Response and Associated Neuronal and White Matter Impairment in the Growth Restricted Newborn.布洛芬治疗可减轻生长受限新生儿的神经炎症反应及相关的神经元和白质损伤。
Front Physiol. 2019 May 10;10:541. doi: 10.3389/fphys.2019.00541. eCollection 2019.
6
A Fragment of Adhesion Molecule L1 Binds to Nuclear Receptors to Regulate Synaptic Plasticity and Motor Coordination.一种黏附分子 L1 的片段与核受体结合,调节突触可塑性和运动协调性。
Mol Neurobiol. 2018 Sep;55(9):7164-7178. doi: 10.1007/s12035-018-0901-7. Epub 2018 Jan 30.
7
Peroxisome proliferator-activated receptor γ (PPARγ): A master gatekeeper in CNS injury and repair.过氧化物酶体增殖物激活受体 γ(PPARγ):中枢神经系统损伤与修复的主控开关。
Prog Neurobiol. 2018 Apr-May;163-164:27-58. doi: 10.1016/j.pneurobio.2017.10.002. Epub 2017 Oct 12.
8
Therapeutic Strategies Under Development Targeting Inflammatory Mechanisms in Amyotrophic Lateral Sclerosis.针对肌萎缩侧索硬化症炎症机制的治疗策略。
Mol Neurobiol. 2018 Apr;55(4):2789-2813. doi: 10.1007/s12035-017-0532-4. Epub 2017 Apr 28.
9
Alzheimer Disease: Crosstalk between the Canonical Wnt/Beta-Catenin Pathway and PPARs Alpha and Gamma.阿尔茨海默病:经典Wnt/β-连环蛋白信号通路与过氧化物酶体增殖物激活受体α和γ之间的相互作用
Front Neurosci. 2016 Oct 19;10:459. doi: 10.3389/fnins.2016.00459. eCollection 2016.
10
Insulin and Insulin-Sensitizing Drugs in Neurodegeneration: Mitochondria as Therapeutic Targets.胰岛素及胰岛素增敏药物在神经退行性变中的作用:线粒体作为治疗靶点
Pharmaceuticals (Basel). 2009 Dec 23;2(3):250-286. doi: 10.3390/ph2030250.